COMP <GO>
NRC vs JNJ // NET PROFIT MARGIN
NRC Health (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: NRC 3
— JNJ 9
▲ NET PROFIT MARGIN LEADER: JNJ
LAST: $23.49 (+0.09%) • MKT CAP: $519.6M
net-margins
8.40%
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
net-margins
28.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NRC VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NRC | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 67.90% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 21.00% | 25.50% | -4.50 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.6x | 18.5x | +0.10 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 3.03% | 2.97% | +0.06 | NRC | /fcf-yield <GO> |
| Operating Margin | 16.40% | 34.70% | -18.30 | JNJ | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 8.40% | 28.50% | -20.10 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | -4.00% | 6.00% | -10.00 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.11% | 0.00% | +2.11 | NRC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.82 | 5.59 | -1.77 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.6 | 62.1 | +1.50 | NRC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 41.7x | 23.0x | +18.70 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $519.6M | $662.49B | -$661.97B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NRC REV | JNJ REV | NRC GROSS % | JNJ GROSS % | NRC FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $137.4M | $94.19B | — | 67.9% | $15.7M | $19.70B |
| FY 2024 | $143.1M | $88.82B | — | 69.1% | $19.2M | $19.84B |
| FY 2023 | $148.6M | $85.16B | — | — | $38.1M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NRC // BETA —
JNJ // BETA 1.08